Decreased Expression of Transcription Elongation Factor A-Like 7 Is Associated with Gastric Adenocarcinoma Prognosis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Huang, Chun yu ^a   Chen, Yong ming ^a   Zhao, Jing jing ^a   Chen, Yi bing ^a   Jiang, Shan shan ^a   Yan, Shu mei ^a   Zhao, Bai wei ^a   Pan, Ke ^a   Wang, Dan dan ^a   Lv, Lin ^a   Li, Yuan fang ^a   Wang, Wei ^a   Zhou, Zhi wei ^a   Xia, Jian chuan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION ELONGATION FACTOR A LIKE 1; TRANSCRIPTION ELONGATION FACTOR A LIKE 3; TRANSCRIPTION ELONGATION FACTOR A LIKE 4; TRANSCRIPTION ELONGATION FACTOR A LIKE 5; TRANSCRIPTION ELONGATION FACTOR A LIKE 6; TRANSCRIPTION ELONGATION FACTOR A LIKE 7; TRANSCRIPTION ELONGATION FACTOR A LIKE 8; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; DISEASE EXACERBATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; OVERALL SURVIVAL; PRIMARY TUMOR; PROTEIN EXPRESSION; RISK ASSESSMENT; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; SURVIVAL TIME; TRANSCRIPTION ELONGATION FACTOR A LIKE 1 GENE; TRANSCRIPTION ELONGATION FACTOR A LIKE 3 GENE; TRANSCRIPTION ELONGATION FACTOR A LIKE 4 GENE; TRANSCRIPTION ELONGATION FACTOR A LIKE 5 GENE; TRANSCRIPTION ELONGATION FACTOR A LIKE 6 GENE; TRANSCRIPTION ELONGATION FACTOR A LIKE 7 GENE; TRANSCRIPTION ELONGATION FACTOR A LIKE 8 GENE; TUMOR GENE; TUMOR VOLUME;

ADENOCARCINOMA; AGED; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTIONAL ELONGATION FACTORS;

EID: 84872861509     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054671     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Yang L, (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20.
3. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730.
4. Chien J, Staub J, Avula R, Zhang H, Liu W, et al. (2005) Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer. Oncogene 24: 5089-5100.
5. Brown AL, Kay GF, (1999) Bex1, a gene with increased expression in parthenogenetic embryos, is a member of a novel gene family on the mouse X chromosome. Hum Mol Genet 8: 611-619.
6. Chien J, Narita K, Rattan R, Giri S, Shridhar R, et al. (2008) A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. Oncogene 27: 7223-7234.
7. Mukai J, Hachiya T, Shoji-Hoshino S, Kimura MT, Nadano D, et al. (2000) NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR. J Biol Chem 275: 17566-17570.
8. Rattan R, Narita K, Chien J, Maguire JL, Shridhar R, et al. (2010) TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway. Oncogene 29: 1362-1373.
9. Peedicayil A, Vierkant RA, Shridhar V, Schildkraut JM, Armasu S, et al. (2009) Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer. Gynecol Oncol 114: 260-264.
10. Lafferty-Whyte K, Bilsland A, Hoare SF, Burns S, Zaffaroni N, et al. (2010) TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression. Neoplasia 12: 405-414.
11. Shridhar V, Sen A, Chien J, Staub J, Avula R, et al. (2002) Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res 62: 262-270.
12. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, et al. (2001) Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 61: 5895-5904.
13. Pillutla RC, Shimamoto A, Furuichi Y, Shatkin AJ, (1999) Genomic structure and chromosomal localization of TCEAL1, a human gene encoding the nuclear phosphoprotein p21/SIIR. Genomics 56: 217-220.
14. Makino H, Tajiri T, Miyashita M, Sasajima K, Anbazhagan R, et al. (2005) Differential expression of TCEAL1 in esophageal cancers by custom cDNA microarray analysis. Dis Esophagus 18: 37-40.
15. Akaishi J, Onda M, Okamoto J, Miyamoto S, Nagahama M, et al. (2006) Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer. BMC Cancer 6: 260.
16. Pan K, Wang H, Chen MS, Zhang HK, Weng DS, et al. (2008) Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma. J Cancer Res Clin Oncol 134: 1247-1253.
17. Zhang HK, Pan K, Wang H, Weng DS, Song HF, et al. (2008) Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett 261: 183-192.
18. Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, et al. (2011) Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma. PLoS One 6: e26608.
19. Wang H, Pan K, Zhang HK, Weng DS, Zhou J, et al. (2008) Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 134: 535-541.
20. Wang W, Lv L, Pan K, Zhang Y, Zhao JJ, et al. (2011) Reduced expression of transcription factor AP-2alpha is associated with gastric adenocarcinoma prognosis. PLoS One 6: e24897.
21. Wang W, Sun XW, Li CF, Lv L, Li YF, et al. (2011) Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients. Ann Surg Oncol 18: 1060-1067.